newheader.jpg
 

Conference Menu

Overview
Day 1
Day 2
Day 3
Register
Download PDF
Hotel & Travel
Sponsor
Press Pass
Request Brochure
Send to a Colleague
 
Corporate Sponsors:
 

Sponsoring Organizations:

The 2007 agenda will feature a number of joint presentations from pairs of end users and IT and informatics partners that provide compelling examples of successful cross-domain partnerships between the organization’s end users and IT and insights into cutting-edge information tools and systems. The content of the presentations will focus on tactics and processes that organizations can effectively and efficiently use to minimize communication gaps between scientists, researchers, and information technology professionals in building solutions and capabilities, utilizing data models and their validation, and integrating drug targets and compounds. The program will also consist of a mix of expert presentations, panels, and round-table discussions.

  • Approximately 80% of the sessions will feature paired speakers from the same or partner organizations who represent the user and the IT perspectives. These paired speakers have successfully bridged a cross-domain partnership

  • Approximately 10% of the sessions will feature an individual speaker who fills the role of the user and IT perspectives in the same job function.

Keynote Presentations

Pre-Conference Workshop*

Day Two: Monday, October 1, 2007

Keynote Session 1: Bridging Diagnostics Technologies with Pharma and Biotech
Tim Jaeger, Ph.D., M.B.A., Head of Medical and Scientific Affairs, Diagnostics Division, F Hoffmann La Roche AG

Keynote Session 2: Creating the IT Infrastructure to Enable Adaptive Clinical Development
The adaptive clinical development process is rapidly being employed by pharmaceutical companies to improve the success rate of late stage clinical programs, shorten development timelines, and permit efficient allocation of resources. As companies move from single trial pilots to broad implementation, the need for an underlying IT infrastructure to support this new process is required. This presentation will discuss the nature of this IT infrastructure and the steps required to achieve it.
Jerald S. Schindler, Dr.P.H., Vice President, Late Stage Clinical Development Statistics, Merck & Co.

Day Three: Tuesday, October 2, 2007

Keynote Session 3: Doubling IT Innovation Spending: Laying the Foundation for IT-Enabled Business Process, Supply Chain, and Service Innovation in the Pharmaceutical Industry
IT leaders within the Pharmaceutical Industry are struggling to meet two critical challenges: dramatically improve the efficiency of IT and use that efficiency to drive business innovation. Over the last few years, Pfizer has been putting in place the processes to dramatically reduce the costs of IT support and maintenance, through the global rationalization of all IT applications, information sources, and the processes which use them. By significantly reducing the cost of IT support and maintenance through global rationalization, Pfizer will be able to use those savings to double the investment available for IT-enabled business process, supply chain, and service innovation across the enterprise. The session will focus on the key steps and lessons that Pfizer has taken to overcome these challenges by focusing in the implementation of an IT/Business Governance Model, IT Portfolio Management Process and a Common IT Architecture and Services Model for supporting Pfizer’s Worldwide Business Development activities.
Chris Asakiewicz, Ph.D., Affiliate Professor of Information Management, Stevens Institute of Technology, Wesley J. Howe School of Technology Management; former Vice President, Global Business Technology, Pfizer Global Pharmaceutical Division

Keynote Session 4: Lessons Learned: Challenges Faced in Sharing Information Across the Organization (Panel)
Marc Wine, MHA, Health Systems Analyst; Adjunct Professor, Health Services Management and Leadership Department, The George Washington University

Donald T. Mon, Ph.D., Vice President, Practice Leadership, American Health Information Management Association (AHIMA)

Mitchell Weisberg, Senior Principal, Hewlett Packard

Day One: Sunday, September 30, 2007

12:00-12:30pm Registration

12:30-4:00 Bridging Business and IT to Implement Performance Metrics
Many Pharmaceutical and Biotechnology companies use an abundance of metrics, scorecards and dashboards to manage their business. But in many cases, these scorecards and dashboards use metrics that are not standardized across the organization – they exist as disparate metrics, compiled manually or on systems that are not integrated. This results in higher reporting costs, and makes it challenging for management to gain insight into multiple groups and divisions of the business with a consistent framework. To respond to these challenges or when developing new metrics, it is vital to engage both the business and IS. A key element to establishing standard metrics across the enterprise is implementing a well defined, consistently executed performance management methodology. This methodology must incorporate and engage the business and IT organizations in a coordinated effort to translate business performance requirements into metrics that are implemented with data and business rules. Clearly defined, standard metrics, anchored to reliable data is a critical success factor for business performance management.

This presentation will provide a case study from Amgen, a leading biotechnology company, to describe how they employed best practices for developing and implementing a common performance metric methodology across the organization. The methodology prescribes both business and technical activities to produce metrics that are aligned with strategy, leading measures of outcome, and drivers of decisions or action. The methodology provides a roadmap and repeatable, standard approach for the pharmaceutical organizations. Participants from both business and IT are encouraged to attend. 
Mitchell Weisberg, Senior Principal, Hewlett Packard 
Paul King, Senior Business Analyst, Amgen Corporation 

*Separate Registration Required

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com